Cymbalta 30 mg Norwegen - Norwegisch - Statens legemiddelverk

cymbalta 30 mg

2care4 aps - duloksetinhydroklorid - enterokapsel, hard - 30 mg

Cymbalta 60 mg Norwegen - Norwegisch - Statens legemiddelverk

cymbalta 60 mg

2care4 aps - duloksetinhydroklorid - enterokapsel, hard - 60 mg

Retsevmo Europäische Union - Norwegisch - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiske midler - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Trulicity 1.5 mg Norwegen - Norwegisch - Statens legemiddelverk

trulicity 1.5 mg

2care4 aps - dulaglutid - injeksjonsvæske, oppløsning - 1.5 mg

Trulicity 3 mg Norwegen - Norwegisch - Statens legemiddelverk

trulicity 3 mg

orifarm as - dulaglutid - injeksjonsvæske, oppløsning - 3 mg

Trulicity 4.5 mg Norwegen - Norwegisch - Statens legemiddelverk

trulicity 4.5 mg

orifarm as - dulaglutid - injeksjonsvæske, oppløsning - 4.5 mg

Mounjaro Europäische Union - Norwegisch - EMA (European Medicines Agency)

mounjaro

eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - legemidler som brukes i diabetes - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 og 5.

Rayvow Europäische Union - Norwegisch - EMA (European Medicines Agency)

rayvow

eli lilly nederland b.v. - lasmiditan succinate - migrene lidelser - analgetika - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Omvoh Europäische Union - Norwegisch - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - kolitt, ulcerativ - immunsuppressive - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

Kisplyx 4 mg Norwegen - Norwegisch - Statens legemiddelverk

kisplyx 4 mg

orifarm as - lenvatinibmesilat - kapsel, hard - 4 mg